http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
Yamazaki, M.,Murakami, H.,Ohtsu, H.,Abe, H.,Takemasa, M. Asian Australasian Association of Animal Productio 2010 Animal Bioscience Vol.23 No.11
Two experiments were conducted to evaluate the effects of addition of sodium polyacrylate (SPA) to a phytasesupplemented diet on the performance and phosphorus (P) retention of chicks. In experiment 1, chicks were randomly allocated to four dietary treatments which were fed from 7 to 21 days of age: i) basal diet (low nonphytate phosphorus (0.23% NPP)); ii) basal with 250 U/kg diet of phytase; iii) as (ii) with 2.5 g/kg diet of SPA; and iv) as (ii) with 5.0 g/kg diet of SPA. In experiment 2, three replicates, each with three chicks, were fed from 7 to 28 days of age the basal diet (0.23% NPP) with supplementation of phytase (0, 300, 600, 900 U/kg diet) and SPA (0, 2.5 g/kg diet) in a $4{\times}2$ factorial arrangement. In Experiment 1, feed efficiency was improved and excreted P was 10% less with phytase supplementation. However, the addition of SPA did not affect performance or P excretion. Dietary SPA supplementation to the diets showed significantly higher amounts of P retention, and highest values were observed in chicks fed 2.5 g/kg of the SPA-supplemented diet. In Experiment 2, feed efficiency was improved with phytase supplementation, and the addition of SPA showed significant improvement in feed efficiency. Excreted P was significantly lower in chicks fed SPA-supplemented diets, and the retained P coefficient improved with SPA supplementation. In conclusion, the increased transit time of digesta with suitable supplementation levels of SPA may allow phytase activity to be more effective in the degradation of phytate, and improve P retention.
Uchino, Junji,Hirano, Ryosuke,Tashiro, Naoki,Yoshida, Yuji,Ushijima, Shinichiro,Matsumoto, Takemasa,Ohta, Keiichi,Nakatomi, Keita,Takayama, Koichi,Fujita, Masaki,Nakanishi, Yoichi,Watanabe, Kentaro Asian Pacific Journal of Cancer Prevention 2012 Asian Pacific journal of cancer prevention Vol.13 No.8
Aims and Background: To evaluate the efficacy of a combination of aprepitant and conventional antiemetic therapy in patients with advanced or recurrent lung cancer receiving moderately emetogenic chemotherapy (MEC). Methods: Patients with advanced or recurrent lung cancer who were treated with MEC regimens at the Department of Respiratory Medicine, Fukuoka University Hospital, were included and classified into the following groups: control group (treatment: 5-HT3 receptor antagonists + dexamethasone) and aprepitant group (treatment: 5-HT3 receptor antagonists + dexamethasone + aprepitant). The presence or absence of chemotherapy-induced nausea and vomiting (CINV) was evaluated according to the Common Terminology Criteria for Adverse Events (CTCAE) v4.0; patients with grade 1 or above were considered positive for CINV. Food intake per day, completion of planned chemotherapy, and progression-free survival (PFS) achieved by chemotherapy were investigated. Results: The complete suppression rate of nausea in the aprepitant group was significantly higher than that in the control group (p = 0.0043). Throughout the study, the food intake in the aprepitant group was greater than that in the control group, with the rate being significantly higher, in particular, on day 5 (p = 0.003). The completion rate of planned chemotherapy was also higher in the aprepitant group (p = 0.042). PFS did not differ significantly, but tended to be improved in the aprepitant group. Conclusions: The aprepitant group showed significantly higher complete suppression of nausea, food intake on day 5, and completion of planned chemotherapy than the control group.